The cost of Pradaxa for Medicare beneficiaries can vary significantly based on several factors, including the specific Medicare plan, the dosage of Pradaxa prescribed, and whether generic alternatives are available [1]. Medicare Part D plans, which cover prescription drugs, have formularies that determine which drugs are covered and at what cost [2].
How much does Pradaxa typically cost without insurance?
Without insurance, the retail price for a 30-day supply of Pradaxa (dabigatran etexilate mesylate) can range from approximately $300 to over $600 for common dosages [1]. This price can fluctuate based on the pharmacy and location [1].
What Medicare plans cover Pradaxa?
Most Medicare Part D plans are expected to cover Pradaxa, as it is a commonly prescribed anticoagulant [2]. However, coverage tiers can impact out-of-pocket costs. Pradaxa is typically found on Tier 2 or Tier 3 of a Medicare Part D formulary, meaning beneficiaries will have a higher copay or coinsurance compared to generic medications on lower tiers [3]. Beneficiaries should verify Pradaxa's inclusion and its tier placement on their specific plan's formulary [2].
How does Medicare Part D coverage work for Pradaxa?
Medicare Part D plans have a coverage gap, also known as the "donut hole," and a catastrophic coverage phase [4]. The cost of Pradaxa will change as beneficiaries progress through these phases [4]. Initially, beneficiaries pay a copay or coinsurance. Once the total drug costs reach a certain limit, they enter the coverage gap, where they pay a higher percentage of the drug's cost. After spending a significant amount out-of-pocket in the coverage gap, they reach catastrophic coverage, where their costs for covered drugs are substantially reduced for the rest of the year [4].
Are there less expensive alternatives to Pradaxa for Medicare beneficiaries?
While Pradaxa is a brand-name drug, other anticoagulant medications exist, including generics and other brand-name drugs with potentially different cost structures on Medicare formularies [5]. However, the choice of medication is ultimately a clinical decision made by a doctor based on a patient's specific medical needs and history [5].
When does Pradaxa's patent expire, and will generics become available?
The patents for Pradaxa have been expiring, and generic versions of dabigatran etexilate mesylate are becoming available [6]. The availability and cost of generic Pradaxa can significantly reduce out-of-pocket expenses for Medicare beneficiaries, as generics are typically placed on lower tiers with lower copays [7]. DrugPatentWatch.com tracks patent expirations for many medications, including Pradaxa [6].
How can I find the exact cost of Pradaxa with my Medicare plan?
To determine the precise cost of Pradaxa with a specific Medicare plan, beneficiaries should consult their plan's formulary or contact their Medicare Part D provider directly [2]. Many Medicare plans also offer online tools or customer service representatives who can provide personalized cost estimates based on the beneficiary's current coverage phase [4].
---
Sources
[1] https://www.goodrx.com/pradaxa
[2] https://www.medicare.gov/drug-coverage-part-d
[3] https://www.medicare.gov/plan-compare/
[4] https://www.medicare.gov/drug-coverage-part-d/medicare-prescription-drug-coverage-ending-or-in-catastrophic-coverage
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749251/
[6] https://drugpatentwatch.com/
[7] https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientHistory.cfm?IngredientName=DABIGATRAN%20ETEXILATE%20METHYLESULPHATE